Eupraxia Pharmaceuticals Announces Voting Results from Annual General and Special Meeting of Shareholders marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its.
Eupraxia Pharmaceuticals Inc. (OTCMKTS:EPRXF – Get Free Report) shares dropped 1.1% during mid-day trading on Wednesday . The stock traded as low as C$2.78 and last traded at C$2.78. Approximately 6,065 shares changed hands during trading, a decline of 18% from the average daily volume of 7,410 shares. The stock had previously closed at C$2.81. […]
Raymond James upgraded shares of Eupraxia Pharmaceuticals (NASDAQ:EPRX – Free Report) to a strong-buy rating in a report published on Wednesday morning, Zacks.com reports. Eupraxia Pharmaceuticals Price Performance Shares of EPRX opened at $2.85 on Wednesday. Eupraxia Pharmaceuticals has a 12-month low of $2.48 and a 12-month high of $6.78. Eupraxia Pharmaceuticals (NASDAQ:EPRX – Get […]